Biotech M&A Deal Looks Too Rich For Its Blood
May 06, 2020 at 11:46 AM EDT
Alexion Pharmaceuticals (ALXN) is either buying Portola Pharmaceuticals (PTLA) on the cheap at $1.4 billion, or paying a whopping premium – it all depends on your starting date.